Jeff Geschwind, MD – Cancer Drug Innovator Founder of Cage Pharma, Jeff Geschwind, MD develops glycolysis-targeting cancer drugs, disrupting tumor metabolism to halt cancer progression. His research offers new hope for aggressive cancers. https://www.bumc.bu.edu/camed/jean-francois-jeff-geschwind-m-d-91-2011-distinguished-alumnus-award/